Target Validation – In the Era of Genomics, Big Data, and AI

About the event

This conference will bring together leading researchers and thought experts from academia, biotech, and pharma. The meeting will focus on the critical elements that power therapeutic hypothesis building, including large-scale genomics data generation and target selection strategies across modalities and therapeutic areas—with AI and emerging technologies taking centre stage. The meeting will explore how these innovations are reshaping the path from discovery to the clinic in both common and rare diseases.